CO7000772A2 - Composiciones farmacéuticas tópicas que comprenden bexaroteno y corticosteroides - Google Patents
Composiciones farmacéuticas tópicas que comprenden bexaroteno y corticosteroidesInfo
- Publication number
- CO7000772A2 CO7000772A2 CO14139629A CO14139629A CO7000772A2 CO 7000772 A2 CO7000772 A2 CO 7000772A2 CO 14139629 A CO14139629 A CO 14139629A CO 14139629 A CO14139629 A CO 14139629A CO 7000772 A2 CO7000772 A2 CO 7000772A2
- Authority
- CO
- Colombia
- Prior art keywords
- bexarotene
- corticosteroids
- pharmaceutical compositions
- topical pharmaceutical
- topical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12000077.3A EP2612665A1 (en) | 2012-01-09 | 2012-01-09 | Topical pharmaceutical compositions comprising bexarotene and a corticosteroide |
| US201261585786P | 2012-01-12 | 2012-01-12 | |
| US201261598095P | 2012-02-13 | 2012-02-13 | |
| EP12000909 | 2012-02-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO7000772A2 true CO7000772A2 (es) | 2014-07-21 |
Family
ID=48781060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO14139629A CO7000772A2 (es) | 2012-01-09 | 2014-06-27 | Composiciones farmacéuticas tópicas que comprenden bexaroteno y corticosteroides |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20140349981A1 (es) |
| EP (1) | EP2802321A1 (es) |
| JP (1) | JP2015503573A (es) |
| KR (1) | KR20140107370A (es) |
| CN (1) | CN104053437A (es) |
| AU (1) | AU2012365658A1 (es) |
| BR (1) | BR112014015578A8 (es) |
| CA (1) | CA2857207A1 (es) |
| CL (1) | CL2014001776A1 (es) |
| CO (1) | CO7000772A2 (es) |
| CR (1) | CR20140326A (es) |
| EA (1) | EA201400806A1 (es) |
| GT (1) | GT201400146A (es) |
| HK (1) | HK1198423A1 (es) |
| IL (1) | IL232765A0 (es) |
| MX (1) | MX2014007300A (es) |
| PE (1) | PE20142375A1 (es) |
| PH (1) | PH12014501573A1 (es) |
| SG (1) | SG11201403762PA (es) |
| WO (1) | WO2013104399A1 (es) |
| ZA (1) | ZA201403483B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4083029A1 (en) | 2013-08-20 | 2022-11-02 | University of Washington through its Center for Commercialization | Novel and specific inhibitors of cytochrome p450 26 retinoic acid hydroxylase |
| WO2016205001A1 (en) | 2015-06-18 | 2016-12-22 | Valeant Pharmaceuticals North America | Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis |
| US11311482B2 (en) | 2017-05-12 | 2022-04-26 | Bausch Health Us, Llc | Topical compositions and methods for treating skin diseases |
| CN113453670A (zh) * | 2018-09-28 | 2021-09-28 | 乔·斯图丁 | 类固醇和大分子的透孔递送 |
| WO2020084548A1 (en) * | 2018-10-26 | 2020-04-30 | Viramal Limited | Mucoadhesive gel composition |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4387463B2 (ja) | 1997-02-20 | 2009-12-16 | アラーガン、インコーポレイテッド | タザロテンおよびコルチコステロイドによる乾癬の処置 |
| CN1210034C (zh) * | 2002-12-06 | 2005-07-13 | 重庆华邦制药股份有限公司 | 治疗银屑病的药物组合物 |
| CN1210035C (zh) | 2003-09-29 | 2005-07-13 | 中国医学科学院皮肤病研究所 | 治疗银屑病的复方外用药物 |
-
2012
- 2012-12-18 CN CN201280066556.XA patent/CN104053437A/zh active Pending
- 2012-12-18 WO PCT/EP2012/005237 patent/WO2013104399A1/en active Application Filing
- 2012-12-18 KR KR1020147018455A patent/KR20140107370A/ko not_active Application Discontinuation
- 2012-12-18 US US14/371,045 patent/US20140349981A1/en not_active Abandoned
- 2012-12-18 EA EA201400806A patent/EA201400806A1/ru unknown
- 2012-12-18 CA CA2857207A patent/CA2857207A1/en not_active Abandoned
- 2012-12-18 SG SG11201403762PA patent/SG11201403762PA/en unknown
- 2012-12-18 PE PE2014000979A patent/PE20142375A1/es not_active Application Discontinuation
- 2012-12-18 JP JP2014550646A patent/JP2015503573A/ja active Pending
- 2012-12-18 AU AU2012365658A patent/AU2012365658A1/en not_active Abandoned
- 2012-12-18 BR BR112014015578A patent/BR112014015578A8/pt not_active Application Discontinuation
- 2012-12-18 EP EP12816241.9A patent/EP2802321A1/en not_active Withdrawn
- 2012-12-18 MX MX2014007300A patent/MX2014007300A/es unknown
-
2014
- 2014-05-14 ZA ZA2014/03483A patent/ZA201403483B/en unknown
- 2014-05-22 IL IL232765A patent/IL232765A0/en unknown
- 2014-06-27 CO CO14139629A patent/CO7000772A2/es unknown
- 2014-07-02 CL CL2014001776A patent/CL2014001776A1/es unknown
- 2014-07-08 CR CR20140326A patent/CR20140326A/es unknown
- 2014-07-08 PH PH12014501573A patent/PH12014501573A1/en unknown
- 2014-07-09 GT GT201400146A patent/GT201400146A/es unknown
- 2014-11-25 HK HK14111918.0A patent/HK1198423A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015503573A (ja) | 2015-02-02 |
| EP2802321A1 (en) | 2014-11-19 |
| PE20142375A1 (es) | 2015-01-11 |
| US20140349981A1 (en) | 2014-11-27 |
| CA2857207A1 (en) | 2013-07-18 |
| WO2013104399A1 (en) | 2013-07-18 |
| BR112014015578A8 (pt) | 2017-07-04 |
| IL232765A0 (en) | 2014-07-31 |
| BR112014015578A2 (pt) | 2017-06-13 |
| HK1198423A1 (en) | 2015-04-24 |
| EA201400806A1 (ru) | 2015-02-27 |
| CR20140326A (es) | 2015-01-16 |
| CL2014001776A1 (es) | 2014-08-29 |
| CN104053437A (zh) | 2014-09-17 |
| GT201400146A (es) | 2015-10-12 |
| KR20140107370A (ko) | 2014-09-04 |
| AU2012365658A1 (en) | 2014-07-03 |
| PH12014501573A1 (en) | 2014-10-08 |
| ZA201403483B (en) | 2015-06-24 |
| SG11201403762PA (en) | 2014-07-30 |
| MX2014007300A (es) | 2014-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289759A (en) | Formulations for local disinfection and their uses | |
| FR21C1059I2 (fr) | Compositions pharmaceutiques | |
| DK3030262T3 (da) | Kombineret farmaceutisk sammensætning | |
| CL2015001157A1 (es) | Composiciones y métodos para tratar proteinopatías. | |
| DK3181122T3 (da) | Farmaceutisk dasatinib-sammensætning | |
| BR112015002738A2 (pt) | composto , e , composição farmacêutica | |
| BR112014021501A2 (pt) | composições farmacêuticas de liberação de óxido nítrico | |
| CL2014002051A1 (es) | Composiciones plaguicidas y procesos relacionados con dichas composiones | |
| DK2882433T3 (da) | Antimikrobielle sammensætninger omfattende glycerylnitrater | |
| BR112013014644A2 (pt) | composição farmacêutica e complexo | |
| BR112014028280A2 (pt) | composições farmacêuticas tópicas compreendendo terbinafina e ureia | |
| DK2897594T3 (da) | Farmaceutisk sammensætning | |
| CL2014002951A1 (es) | (r)-nifuratel; formulacion farmaceutica que lo contiene; y proceso para fabricar (r)-nifuratel y (s)-nifuratel. | |
| FI20125888A (fi) | Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö | |
| CO7000772A2 (es) | Composiciones farmacéuticas tópicas que comprenden bexaroteno y corticosteroides | |
| GB201320932D0 (en) | Topical pharmaceutical composition | |
| DK3156060T3 (da) | Farmaceutiske sammensætninger og topisk anvendelse deraf | |
| BR112015002646A2 (pt) | composto e composição farmacêutica | |
| HK1213813A1 (zh) | 種含埃克替尼的皮膚外用藥物組合物及其應用 | |
| BR112015014078A2 (pt) | composição farmacêutica oftalmológica tópica que contém regorefenib | |
| DK2934510T3 (da) | Lfa-1-inhibitorformuleringer | |
| BR112014017217A2 (pt) | agente e composição farmacêutica | |
| IL235154A0 (en) | Preparations containing substances to reduce uric acid and anti-inflammatory substances and their uses | |
| CO6990712A2 (es) | Combinación farmacéutica antineuritica y composiciones | |
| BR112014008014A2 (pt) | métodos farmacêuticos e composições tópicas contendo acitretina |